Client login From 24 June 2024, the new name for Across Health is Precision AQ!…. Read more

Embrace the new Matrix

Step 4: Monitor campaign impact

Money matters. The results of our 2021 Maturometer confirm that despite the growth of digital budgets, the industry continues to struggle with measuring the ROI of digital. Our omnichannel case study shows how solid impact measurement can influence key-decision making and build the bridge between marketing & sales. 

Are you looking for more OCE case studies? Have a look at Navigator365™ Learning, which is a highly interactive multidisciplinary capability-building platform for omnichannel engagement excellence in biopharma and is stuffed with interactive modules, case studies, playbooks, checklists, channels guides and tailored learning plans. Watch the guided tour here.

Monitoring campaign impact is step 4 of our 4-step evidence-based OCE toolkit that is custom-designed to help biopharma companies plan and execute OCE campaigns for the Never Normal. View all resources here.

 

Want to receive the Across Health newsletter?


Or follow us on  LinkedIn

+

Share this article

Use your preferred feature.


Or share this page with a colleague.

+

Healthcare Innovation Tour 2020

To register your interest in joining the tour, and to comply with GDPR so we may send you future emails, please fill out the following information and complete the consent section at the bottom.

+

+

Book an exploratory call

Submit your details via this short form and you will be invited by one of our experts for a free 30-minute call to explore how Navigator365TM can provide an answer to your ambitions, needs and challenges.

+
+

Across Health is evolving...

From 24 June 2024, the new name for Across Health is Precision AQ! This change is happening in-line with the rebranding being undertaken by the entire Precision Value & Health team (of which we have been a part since February 2021).

Having joined forces with over 1,200 life-science experts, advisors and creatives across 100+ diverse fields, we will continue to partner with our clients to deliver evidence-based omnichannel engagement strategies while empowering access to life-changing medicines for all.

While we transition across to our new website, click here to see how we are already focusing on HCP engagement in the digital age, fuelled by powerful insights from our Navigator365TM research.

To find out more about our wider global services and unified mission, read our publication here.

+